Atomoxetine hydrochloride (Atomoxetine HCl, Tomoxetine hydrochloride, Tomoxetine HCl, LY 139603, LY139603)，又称盐酸阿托西汀或盐酸托莫西汀，是去甲肾上腺素重吸收抑制剂，K_i为5 nM，通过抑制去甲肾上腺素转运蛋白，阻碍去甲肾上腺素再摄取进入突触前神经末端。临床上，Atomoxetine hydrochloride用于治疗注意缺陷障碍伴多动症。

参考文献

1.McAfee AT, Landon J, Jones M, et al. A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications. Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):386-93.

2.Turner M, Wilding E, Cassidy E, Dommett EJ. Effects of atomoxetine on locomotor activity and impulsivity in the spontaneously hypertensive rat. Behav Brain Res. 2013 Apr 15;243:28-37.

3.Owens MJ, Morgan WN, Plott SJ, Nemeroff CB. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther. 1997 Dec;283(3):1305-22.

冰袋运输。粉末直接保存于-20℃，有效期3年。建议分装后-20℃干燥保存，避免反复冻融。